Back

Right ventricular function as a predictor of appropriate therapy of implantable cardioverter defibrillator

25 April 2021 (15:15 - 16:10)
Organised by:
Congress Presentation Part of: New insights into ICD therapy Implantable Cardioverter-Defibrillator (ICD) EHRA Premium Access EHRA 2021

About the speaker

Photo
Doctor Toshinori Chiba

Charité - University Medicine Berlin, Berlin (Germany)

4 More presentations in this session

Presentation thumbnail
Prognostic Nutritional Index as the Predictor of Long-Term Mortality among HFrEF Patients with ICD
Doctor G. Cinier (Istanbul, TR)
Abstract Slides Video
Presentation thumbnail
Heart failure monitoring using the wearable cardioverter defibrillator in patients with newly diagnosed heart failure
Doctor H. Hillmann (Hannover, DE)
Abstract Slides Video
Presentation thumbnail
Single center experience of ICD implantation in pediatric age
Doctor J. Fumanelli (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Long-term mortality benefit of adding an ICD to CRT in non-ischemic patients
Ms B. Veres (Budapest, HU)
Abstract Slides Video

Access the full session

Session thumbnail
New insights into ICD therapy

The Event

Event poster

EHRA 2021

25 April 2021 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Early rhythm control promotes ventricular recovery and reduces ICD requirement in idiopathic LVSD with arrhythmia under WCD protection
thumbnail
Congress Presentation
Right Ventricular Dysfunction is Associated with Adverse Prognosis in Patients with Cardiac Sarcoidosis
thumbnail
Congress Presentation
Prognostic value of right ventricular ejection fraction using three-dimensional echocardiography in patients with ischemic cardiomyopathy and dilated cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources